Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Bio-Protocol
|
May 21, 2019
Murine Pharmacokinetic Studies
Alix F Leblanc, Kevin M Huang, Muhammad Erfan Uddin, et al.
Journal of Pharmaceutical Sciences
|
October 5, 2024
Improving oral absorption of a rapidly crystallizing parent drug using prodrug strategy: Comparison of phosphate versus glycine based prodrugs
Anura S Indulkar, Russell Slade, Navendu Jana, et al.
Archives of Toxicology
|
April 9, 2016
Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells
Eléonore A Attignon, Alix F Leblanc, Béatrice Le-Grand, et al.
Clinical and Translational Science
|
November 20, 2025
Optimization of Bottom-Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data
Julia A Schulz Pauly, Alix F Leblanc, Ekram A Chowdhury, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 5, 2017
Down-regulation of the expression of alcohol dehydrogenase 4 and CYP2E1 by the combination of α-endosulfan and dioxin in HepaRG human cells
Eléonore A Attignon, Emilie Distel, Béatrice Le-Grand, et al.
Environmental Health Perspectives
|
October 8, 2016
Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model
Caroline Duval, Fatima Teixeira-Clerc, Alix F Leblanc, et al.
Environmental Research
|
September 15, 2019
A dual mixture of persistent organic pollutants modifies carbohydrate metabolism in the human hepatic cell line HepaRG
Alix F Leblanc, Eléonore A Attignon, Emilie Distel, et al.
The AAPS Journal
|
July 19, 2022
Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group Survey
Carl Petersson, Xin Zhou, Joerg Berghausen, et al.
Clinical Pharmacology and Therapeutics
|
October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective
Micaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
The Journal of Clinical Investigation
|
January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
Alix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Bio-Protocol
|
May 21, 2019
Murine Pharmacokinetic Studies
Alix F Leblanc, Kevin M Huang, Muhammad Erfan Uddin, et al.
Journal of Pharmaceutical Sciences
|
October 5, 2024
Improving oral absorption of a rapidly crystallizing parent drug using prodrug strategy: Comparison of phosphate versus glycine based prodrugs
Anura S Indulkar, Russell Slade, Navendu Jana, et al.
Archives of Toxicology
|
April 9, 2016
Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells
Eléonore A Attignon, Alix F Leblanc, Béatrice Le-Grand, et al.
Clinical and Translational Science
|
November 20, 2025
Optimization of Bottom-Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data
Julia A Schulz Pauly, Alix F Leblanc, Ekram A Chowdhury, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
July 5, 2017
Down-regulation of the expression of alcohol dehydrogenase 4 and CYP2E1 by the combination of α-endosulfan and dioxin in HepaRG human cells
Eléonore A Attignon, Emilie Distel, Béatrice Le-Grand, et al.
Environmental Health Perspectives
|
October 8, 2016
Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model
Caroline Duval, Fatima Teixeira-Clerc, Alix F Leblanc, et al.
Environmental Research
|
September 15, 2019
A dual mixture of persistent organic pollutants modifies carbohydrate metabolism in the human hepatic cell line HepaRG
Alix F Leblanc, Eléonore A Attignon, Emilie Distel, et al.
The AAPS Journal
|
July 19, 2022
Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group Survey
Carl Petersson, Xin Zhou, Joerg Berghausen, et al.
Clinical Pharmacology and Therapeutics
|
October 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective
Micaela B Reddy, Tamara D Cabalu, Loeckie de Zwart, et al.
The Journal of Clinical Investigation
|
January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
Alix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
Page
of 2